Daria Kifjak, Rebecca Mura, Svitlana Pochepnia, Nino Bogveradze, Aida Korajac, Benedikt H Heidinger, Ruxandra-Iulia Milos, Lucian Beer, Helmut Prosch
{"title":"Beyond the usual - Atypical imaging presentation in lung cancer and implications for TNM-staging.","authors":"Daria Kifjak, Rebecca Mura, Svitlana Pochepnia, Nino Bogveradze, Aida Korajac, Benedikt H Heidinger, Ruxandra-Iulia Milos, Lucian Beer, Helmut Prosch","doi":"10.1097/CCO.0000000000001203","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review illustrates the spectrum of atypical computed tomography (CT) appearances of lung cancer and provides practical guidance for accurate diagnosis and staging.</p><p><strong>Recent findings: </strong>While most lung cancers show typical CT features, certain subtypes present atypically, mimicking benign conditions or other malignancies. These include pneumonic-type adenocarcinoma, multifocal adenocarcinoma with ground-glass/lepidic features, lung cancer with air lucency, and pulmonary carcinoid tumors. Pneumonic-type adenocarcinoma often resembles infectious pneumonia, requiring careful CT evaluation, and tissue sampling for confirmation. Multifocal ground-glass/lepidic adenocarcinomas, most commonly seen in female never-smokers, are indolent with low metastatic potential. Lung cancers with air lucency, appearing as cysts, cavitary, or bullous lesions, challenge volumetric assessment and may benefit from adapted TNM measurements excluding air-space components. Pulmonary carcinoid tumors show variable imaging features and require tailored staging and management based on their differentiation and spread.</p><p><strong>Summary: </strong>Accurate recognition of atypical CT manifestations of lung cancer is critical to avoid misinterpretation and inappropriate management. Integrating imaging characteristics with histopathologic and, when applicable, molecular data ensures correct staging and guides personalized therapy.</p>","PeriodicalId":10893,"journal":{"name":"Current Opinion in Oncology","volume":" ","pages":"31-38"},"PeriodicalIF":2.4000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12700679/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCO.0000000000001203","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: This review illustrates the spectrum of atypical computed tomography (CT) appearances of lung cancer and provides practical guidance for accurate diagnosis and staging.
Recent findings: While most lung cancers show typical CT features, certain subtypes present atypically, mimicking benign conditions or other malignancies. These include pneumonic-type adenocarcinoma, multifocal adenocarcinoma with ground-glass/lepidic features, lung cancer with air lucency, and pulmonary carcinoid tumors. Pneumonic-type adenocarcinoma often resembles infectious pneumonia, requiring careful CT evaluation, and tissue sampling for confirmation. Multifocal ground-glass/lepidic adenocarcinomas, most commonly seen in female never-smokers, are indolent with low metastatic potential. Lung cancers with air lucency, appearing as cysts, cavitary, or bullous lesions, challenge volumetric assessment and may benefit from adapted TNM measurements excluding air-space components. Pulmonary carcinoid tumors show variable imaging features and require tailored staging and management based on their differentiation and spread.
Summary: Accurate recognition of atypical CT manifestations of lung cancer is critical to avoid misinterpretation and inappropriate management. Integrating imaging characteristics with histopathologic and, when applicable, molecular data ensures correct staging and guides personalized therapy.
期刊介绍:
With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.